KARIN EASTHAM
CIK 1231845 · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.19M
Companies
10
Total Filings
145
Lifetime Open-Market Net
-$168.64M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PSNL | Director | 19,756 | $9.59 | $189.5K | $0 | 9 | 2026-06-11 |
| VCYT | Director | 18,554 | $47.33 | $878.2K | -$150.10M | 29 | 2025-12-08 |
| GERN | Director | 109,047 | $1.15 | $125.4K | $0 | 22 | 2023-01-17 |
| NKTR | Director | 23,233 | $59.38 | $1.38M | -$76.8K | 7 | 2022-09-20 |
| ILMN | Director | 10,049 | $160.97 | $1.62M | -$18.46M | 34 | 2019-05-28 |
| Trius Therapeutics Inc (TSRX) Delisted | Director | 18,114 | — | — | $0 | 6 | 2013-05-23 |
| AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Director | 6,000 | — | — | $0 | 19 | 2012-05-17 |
| GENOPTIX INC (GXDX) Delisted | Director | 0 | — | — | $0 | 10 | 2011-03-07 |
| SGX PHARMACEUTICALS, INC. (SGXP) Delisted | Director | 0 | — | — | $0 | 4 | 2008-08-21 |
| TERCICA INC (TRCA) Delisted | Director | 13,333 | $7.87 | $104.9K | $0 | 2 | 2008-05-21 |
Recent Filings · Page 10 of 15
145 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-04-20 | ILMN | Grant (A) | +1,440 | $0 | EDGAR |
| 2012-03-29 | Trius Therapeutics Inc (TSRX) Delisted | Exer (M) | +6,000 | $21.0K | EDGAR |
| 2011-06-06 | Trius Therapeutics Inc (TSRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-06-03 | ILMN | Mixed | — | -$662.0K | EDGAR |
| 2011-05-25 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Grant (A) | +3,000 | $0 | EDGAR |
| 2011-05-24 | GERN | Grant (A) | +5,000 | $0 | EDGAR |
| 2011-05-13 | GERN | Grant (A) | +9,000 | $0 | EDGAR |
| 2011-05-11 | ILMN | Mixed | +720 | -$52.8K | EDGAR |
| 2011-03-21 | ILMN | Mixed | — | -$282.3K | EDGAR |
| 2011-03-07 | GENOPTIX INC (GXDX) Delisted | U | −2,500 | -$62.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.